Clinical Trial Update: Study to Evaluate Apo805K1 in Subjects With Moderate to Severe Chronic Plaque Psoriasis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating Apo805K1 in adults with moderate-to-severe chronic plaque psoriasis has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Apo805K1

Snippet

Sponsor: ApoPharma | Conditions: Plaque Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2015-02-20